Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for low cardiac output syndrome after cardiopulmonary bypass in infants and young children with congenital heart disease
ChiCTR1800016594Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in low cardiac output syndrome (LCOS) (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Levosimendan concentration, Cardiac troponin I and 3 more. Started Jun 2018; status: recruiting.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on ChiCTR1800016594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016594.